全文获取类型
收费全文 | 2520篇 |
免费 | 233篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 5篇 |
妇产科学 | 9篇 |
基础医学 | 144篇 |
口腔科学 | 6篇 |
临床医学 | 59篇 |
内科学 | 44篇 |
皮肤病学 | 7篇 |
神经病学 | 3篇 |
特种医学 | 22篇 |
外国民族医学 | 1篇 |
外科学 | 45篇 |
综合类 | 452篇 |
预防医学 | 41篇 |
眼科学 | 4篇 |
药学 | 1129篇 |
中国医学 | 602篇 |
肿瘤学 | 336篇 |
出版年
2024年 | 23篇 |
2023年 | 53篇 |
2022年 | 69篇 |
2021年 | 72篇 |
2020年 | 84篇 |
2019年 | 79篇 |
2018年 | 97篇 |
2017年 | 110篇 |
2016年 | 80篇 |
2015年 | 110篇 |
2014年 | 181篇 |
2013年 | 206篇 |
2012年 | 161篇 |
2011年 | 208篇 |
2010年 | 123篇 |
2009年 | 107篇 |
2008年 | 132篇 |
2007年 | 128篇 |
2006年 | 106篇 |
2005年 | 96篇 |
2004年 | 74篇 |
2003年 | 67篇 |
2002年 | 58篇 |
2001年 | 73篇 |
2000年 | 52篇 |
1999年 | 50篇 |
1998年 | 41篇 |
1997年 | 31篇 |
1996年 | 37篇 |
1995年 | 22篇 |
1994年 | 17篇 |
1993年 | 23篇 |
1992年 | 21篇 |
1991年 | 17篇 |
1990年 | 17篇 |
1989年 | 13篇 |
1988年 | 17篇 |
1987年 | 9篇 |
1986年 | 8篇 |
1985年 | 4篇 |
1984年 | 8篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 1篇 |
排序方式: 共有2911条查询结果,搜索用时 15 毫秒
1.
苦碟子抗肿瘤作用的实验性研究 总被引:4,自引:0,他引:4
目的 研究苦碟子对动物移植性肿瘤的作用。方法 以小鼠移植性肉瘤180(S180)和艾氏腹水瘤(EAC)为模型,观察苦碟子的抗肿瘤作用,并分别计算出抑瘤率和生命延长率。结果 不同剂量的苦碟子对小鼠肉瘤S180的抑制率分别为39.86%,38.14%和35.73%(与对照组相比差异有显著性,P<0.01),苦碟子也能延长荷艾氏腹水瘤(EAC)小鼠的存活期,生命的延长率分别为41.27%、29.79%和17.88%(高剂量组和中等剂量组与对照组相比差异有显著性,P<0.01)。结论 苦碟子在动物体内可能具有抗肿瘤作用,可作为一种有前途的抗肿瘤药物进行研究。 相似文献
2.
Jing‐Ping Zhang Limin Zheng Jiang‐Hai Wang Karl‐Eric Magnusson Xin Liu 《Phytotherapy research : PTR》2009,23(6):844-850
Ganoderma sinensis has been used widely in Oriental countries for the prevention and treatment of various diseases including cancer. Previous studies have shown that the lipid extract from Ganoderma exhibits direct cytotoxicity against tumor cells. Here, it is reported that the lipid extract from germinating G. sinensis spores, at lower concentrations that have no direct tumoricidal activity, induce potent antitumor immune responses in human monocytes/macrophages. Upon stimulation with the lipid extract, monocytes/macrophages exhibited markedly increased production of proinflammatory cytokines and surface expression of costimulatory molecules. Conditioned medium from stimulated cells effectively suppressed the growth of tumor cells. Apparently, the lipid extract triggered macrophage activation via a mechanism different from that associated with LPS. Moreover, it was observed that the lipid extract could partially re‐establish the antitumor activity of the immunosuppressive tumor‐associated macrophages. These results indicated that in addition to its direct tumoricidal activity, the lipid extract from G. sinensis spores could exert antitumor activity by stimulating the activation of human monocytes/macrophages. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
3.
研究了十字花科蔬菜提取物6320(主要含异硫氰酸酯)的抗肿瘤活性。体外实验应用MTT法、观察细胞形态、测定细胞生长曲线、流式细胞仪分析细胞凋亡及细胞周期观察提取物6320对不同肿瘤细胞生长的影响。并通过建立小鼠B16实体瘤模型来考察提取物6320的体内抗肿瘤作用。结果表明提取物6320在体内外均可明显抑制肿瘤的生长及增殖,并诱导细胞凋亡,但有可能对机体的免疫系统造成一定的影响。 相似文献
4.
Fumio Nakajima Tomohiko Asano Masamichi Hayakawa Hiroshi Nakamura 《International journal of urology》1996,3(1):s19-s21
We evaluated nitric oxide induction in antitumor therapy consisting of anti–CD3 monoclonal antibody (anti–CD3) and interleukin–2 (IL–2), then determined the effect of nitric oxide reduction with L–NG –monomethyl arginine (LNMA) on the therapeutic methods. Female C57BL/6 mice, MCA102 (a non immunogenic, NK–resistant murine fibrosarcoma cell line), and 145–2C11 (hamster anti–murine–CD3 mAb) were utilized in an experimental hepatic metastasis model developed by injecting a tumor cell suspension into the spleen of mice. A marked increase in serum NO2 – + NO1 was observed at 19 hours after anti–CD3 (10 μ, IV) and additional IL–2 administrations (40times101 U, twice, If) induced a further increase. The NO2 , + NO3- elevation in spot urine in the combination therapy was not suppressed with LNMA at a dose of 100 μg/h but was significantly lowered at 300 μg/h. The efficacy of the anti–CD3 + IL–2 therapy was not diminished by LNMA administration either at 100 μg/h or at 300 μg/h. 相似文献
5.
4-甲氧基-2-巯基-N-氧化吡啶钠的抗肿瘤及免疫抑制作用 总被引:1,自引:0,他引:1
4-个甲氧基-2-巯基-N-氧化吡啶钠(4-甲氧基巯氧吡啶钠,SodiumMethoxypyridinethione,SMPT)在试管内0.01mg·L-1可抑制多种传代人癌细胞林,抑制细胞有丝分裂和损害细胞膜相结构,单用对动物移植性肿瘤无效,但明显增强氟脲嘧啶对小鼠S180的抑癌作用。使胸腺和脾脏重量明显减轻,抑制SRBC诱导的小鼠血清溶血素反应,抑制DNCB诱导的豚鼠皮肤迟发型超敏反应,抑制PHA诱导的大鼠3H-TdR参入的淋巴细胞转化。与2-巯基-N-氧化吡啶钠(巯氧吡啶钠,SodiumPyridinethione.SPT)比较,小鼠LD50(ip)增大,而试管内抑瘤的IC50相近。 相似文献
6.
羟基胆烷酸类衍生物的抗癌活性研究Ⅰ.3β,5α,6β-三羟基胆烷-24-酸及其衍生物的合成与体外抗癌活性 总被引:3,自引:0,他引:3
报道3β,5α,6β三羟基胆烷24酸及其衍生物的合成及对小鼠L1210白血病细胞的体外抗癌活性.实验表明3β,5α,6β三羟基胆烷24酸,3β,5α,6β三羟基胆烷24酸甲酯及3β,6β二乙酰氧基5α羟基胆烷24酸甲酯有较好的抗癌活性 相似文献
7.
Rolf W. Hartmann Martin Frotscher Dorothea Ledergerber Gerald A. Wchter Gertrud L. Grün Tom F. Sergejew 《Archiv der Pharmazie》1996,329(5):251-261
In search of potential drugs for the treatment of estrogen- and androgen-dependent cancer as well as the prophylaxis of metastases, tetralones, tetralins, and dihydronaphthalenes bearing a OCH3 substituent at the benzene nucleus and an imidazol-4-yl, imidazol-1-yl, or 1,2,4-triazol-1-yl substituent in 2-position were synthesized with and without C1-spacer between the rings (compounds 2 – 26 ). The compounds were tested in vitro for inhibition of the three target enzymes P450 arom (human placental microsomes), P450 17 (rat testicular microsomes), and P450 TxA2 (citrated human whole blood). To examine selectivity, some compounds were further tested in vitro for inhibition of P450 18 (bovine adrenal mitochondria), P450 see (bovine adrenal mitochondria) and corticoid formation (aldosterone, corticosterone; ACTH stimulated rat adrenal tissue). In vivo, selected compounds were examined in Sprague Dawley rats regarding P450 TxA2 inhibition, reduction of plasma testosterone concentration, antiuterotrophic activity (inhibition of the uterotrophic activity of androstenedione), reduction of plasma estradiol concentration (pregnant mares' serum gonadotropin-primed rats), and mammary tumor inhibiting activity (dimethylbenzanthracene-induced tumor; pre- and postmenopausal model). In the series of imidazol-4-yl compounds, which represent a novelty in the field of azole inhibitors of steroidogenic P450 enzymes, strong inhibitors of P450 arom and/or P450 17 were found: 7-OCH3-2-(imidazol-4-ylmethylene)-1-tetralone ( 4 ) and 7-OCH3-2-(imidazol-4-ylmethyl)-tetralin ( 12 ) are among the most potent inhibitors of P450 arom in vitro known so far. Compound 4 is a selective inhibitor, whereas 12 shows in addition strong inhibition of P450 17. In contrast to 12 , the 6-OCH3 derivative (compound 11 ) is a selective inhibitor of P450 17, being 50 times more potent than ketoconazole. Some imidazol-1-yl compounds show a marked inhibition of P450 TxA2: 2-(imidazol-1-ylmethyl)-1-tetralone ( 13 ) is a selective inhibitor of P450 TxA2, whereas 7-OCH3-2-(imidazol-1-ylmethyl)-tetralin ( 17 ) as well as 2-(imidazol-1-ylmethyl)-tetralin ( 16 ) and 7-OCH3-2-imidazol-1-yl-3,4-dihydronaphthalene ( 25 ) additionally show strong inhibition of P450 arom and P450 17. Regarding the other steroidogenic P450 enzymes as well as corticosterone formation, the compounds show only little inhibitory activity. Aldosterone formation, however, is inhibited at low concentrations. Nevertheless, 4 and 12 are more selective, i.e. inhibit aldosterone synthesis less than the well known inhibitor of P450 arom fadrozole. The compounds show activity in the aforementioned in vivo tests. 相似文献
8.
Dr. Franco Zunino Brunella Barbieri Ornella Bellini Anna Maria Casazza Cristina Geroni Fernando Giuliani Antonio Ciana Giorgio Manzini Franco Quadrifoglio 《Investigational new drugs》1986,4(1):17-23
Summary The chromophore-modified derivative of doxorubicin, 4-demethyl-6-0-methyl-doxorubicin, has been tested for antitumor activity in a range of experimental murine tumor systems. In contrast to the inactive 6-0-methyl derivative of daunorubicin, 4-demethyl-6-0-methyl-doxorubicin provided antitumor effects comparable to that of the parent compound. In addition, detailed DNA-interaction studies showed that the doxorubicin derivative retains the ability to bind DNA by the intercalation mechanism. However, the binding affinity was appreciably reduced following structural modification in the anthraquinone chromophore. On the basis of the proposed models of intercalation, these results could be rationalized in terms of steric influence of the bulky methoxy group. The results of this study are in agreement with the correlation already observed between DNA binding and relative antitumor activity of anthracyclines. 相似文献
9.
一种新型人TNFα对人肝癌裸鼠移植瘤的抗瘤作用 总被引:1,自引:1,他引:0
用人肝癌Bel7402瘤株建立了人肝癌裸鼠移植瘤模型,探讨新型重组人TNFa对这种移植瘤的抗瘤作用,结果表明,rhTFaD11a和原型重组人TNFa的抑瘤率在30%左右时,后者后用的活性产闰数是前者的2倍;两者用量相同时,前者的抑产经比后者提高23个百分 相似文献
10.
研究人胚胎横纹肌条件培养液产生的生物因子(ATP-FMCM)抗瘤活性。观察发现ATF对8种肿瘤细胞株体外增殖有抑制作用。对BGC-823等6种瘤细胞的抑制率均有52% ̄94%之间。其中对BGC-823、V-7221和Hela3株瘤细胞的抑制率最高,分别为94%、93%和85%。整体抑瘤实验证实,ATF能明显减轻S-180荷瘤小鼠腹水的严重程度,生存时间延长,并能有效抑制LA-795肺腺癌荷瘤小鼠的 相似文献